(Q84140444)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20433992%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

The National Comprehensive Cancer Center Network (NCCN) guidelines on the management of venous thromboembolism in cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20433992%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

main subject

venous thromboembolism

1 reference

Michael B Streiff

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20433992%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

National Comprehensive Cancer Center Network

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20433992%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

1 April 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20433992%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20433992%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

125 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20433992%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

S128-33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20433992%20AND%20SRC:MED&resulttype=core&format=json

Venous thromboembolic disease. Clinical practice guidelines in oncology

1 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Malignancies, prothrombotic mutations, and the risk of venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Thromboembolism in hospitalized neutropenic cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Development and validation of a predictive model for chemotherapy-associated thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Venous thromboembolism in the hematologic malignancies.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1514 patients undergoing hematopoietic stem cell transplantation: implications for VTE prevention.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Why does prophylaxis with external pneumatic compression for deep vein thrombosis fail?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open-label study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Venous Thromboembolism Associated With Long-Term Use of Central Venous Catheters in Cancer Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Prevention of catheter-related venous thrombosis with nadroparin in patients receiving chemotherapy for hematologic malignancies: a randomized, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Accuracy and usefulness of a clinical prediction rule and D-dimer testing in excluding deep vein thrombosis in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Computed tomographic pulmonary angiography vs ventilation-perfusion lung scanning in patients with suspected pulmonary embolism: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Dabigatran versus warfarin in the treatment of acute venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Secondary prevention of venous thromboembolic events in patients with active cancer: enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day period

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

A pilot study of central venous catheter survival in cancer patients using low-molecular-weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study).

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Is it worth diagnosing and treating distal deep vein thrombosis? No

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Distal DVT: worth diagnosing? Yes.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Comparative study on risk factors and early outcome of symptomatic distal versus proximal deep vein thrombosis: Results from the OPTIMEV study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Comparison of the clinical history of symptomatic isolated distal deep-vein thrombosis vs. proximal deep vein thrombosis in 11 086 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Catheter-directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short-term patency

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Deep venous thrombosis: the opportunity at hand

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Twenty-one-year trends in the use of inferior vena cava filters

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

The role of vena caval filters in the management of venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Tinzaparin in outpatients with pulmonary embolism or deep vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Home therapy for deep vein thrombosis and pulmonary embolism in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Prospective validation of the Pulmonary Embolism Severity Index. A clinical prognostic model for pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mm Hg or higher.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Right ventricular enlargement on chest computed tomography: a predictor of early death in acute pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Treatment for superficial thrombophlebitis of the leg

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

High vs. low doses of low-molecular-weight heparin for the treatment of superficial vein thrombosis of the legs: a double-blind, randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

A pilot randomized double-blind comparison of a low-molecular-weight heparin, a nonsteroidal anti-inflammatory agent, and placebo in the treatment of superficial vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

Cancer-associated thrombosis: prevention and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970030-X

7 January 2021

10.1016/S0049-3848(10)70030-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20433992%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference